Talphera, Inc. (TLPH) short interest & options flow
NASDAQTalphera just reported Q1 2026 results after the close on May 13, and the headline number was better than feared. EPS came in at $(0.04), beating the $(0.07) estimate — a meaningful outperformance for a pre-revenue micro-cap biotech that closed the day at $0.86. Revenue was effectively nil, consistent with the company's clinical-stage status, but the loss rate is narrowing. The…
- Market cap
- $55M
- Next earnings
- 12 Nov 2026
Key data as of 12 Nov 2026

TLPH news and analysis
RSSNo long-form analysis yet for TLPH. Pulse alerts and the live data picture are available on ORTEX.
Open TLPH on ORTEX →Want the live picture for TLPH?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for TLPH — free to start on ORTEX.
Sign up for free →Open TLPH on ORTEX